ReviewTherapeutic advances in neurological disorders2019
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment.
Luisa Klotz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this paperpooled ittrialcites it